You mean when we start getting Licensing/Partnership deals on MANF indications and we have more money than Apple. Yes, at some point we'll have the money to do a share buy back. But do you think we'll be in that position within the next year? Whereas, I'm thinking Gerald wants to up list...yesterday! So, by margining within days of up listing, and maybe even before a LymPro Sales Partner is announced, one could really score big time using margin money. Risk is involved, no doubt, but everyone who has invested in this stock in the first place...seems comfortable with risk.